Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul T Edlefsen

Showing results (31-40 of 81) with videos related to

Pageof 9
Sort By:
Journal of Virology|November 15, 2022
Transient T Cell Expansion, Activation, and Proliferation in Therapeutically Vaccinated Simian Immunodeficiency Virus-Positive Macaques Treated with N-803Olivia E Harwood, Alexis J Balgeman, Abigail J Weaver, et al.
Frontiers in Virology (Lausanne, Switzerland)|June 29, 2023
Evaluation of the immunogenicity and efficacy of an rVSV vaccine against Zika virus infection in macaca nemestrinaJennifer Tisoncik-Go, Kathleen M Voss, Thomas B Lewis, et al.
Frontiers in Immunology|June 4, 2025
SIV/SARS-CoV-2 coinfection in rhesus macaques impacts viral shedding, host immunity, the microbiome, and viral evolutionMegan N Fredericks, Zohar Kolodner, Adam Waalkes, et al.
Research Square|April 8, 2025
SIV/SARS-CoV-2 co-infection in rhesus macaques impacts viral shedding, host immunity, the microbiome, and viral evolutionMegan N Fredericks, Zohar Kolodner, Adam Waalkes, et al.
Science Translational Medicine|July 19, 2019
Enhancing safety of cytomegalovirus-based vaccine vectors by engaging host intrinsic immunityEmily E Marshall, Daniel Malouli, Scott G Hansen, et al.
Plos Computational Biology|April 2, 2019
Prediction of VRC01 neutralization sensitivity by HIV-1 gp160 sequence featuresCraig A Magaret, David C Benkeser, Brian D Williamson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 9, 2023
T-SPOT.TB Reactivity in Southern African Children With and Without in Utero Human Immunodeficiency Virus ExposureSaori C Iwase, Paul T Edlefsen, Lynnette Bhebhe, et al.
Biorxiv : the Preprint Server for Biology|August 19, 2022
A replicon RNA vaccine induces durable protective immunity from SARS-CoV-2 in nonhuman primates after neutralizing antibodies have wanedMegan A Oâ Connor, David W Hawman, Kimberly Meade-White, et al.
Plos One|January 24, 2019
Cytomegalovirus vectors expressing Plasmodium knowlesi antigens induce immune responses that delay parasitemia upon sporozoite challengeScott G Hansen, Jennie Womack, Isabel Scholz, et al.
Ebiomedicine|January 20, 2015
Vaccine-induced Human Antibodies Specific for the Third Variable Region of HIV-1 gp120 Impose Immune Pressure on Infecting VirusesSusan Zolla-Pazner, Paul T Edlefsen, Morgane Rolland, et al.
Pageof 9

Showing results (31-40 of 81) with videos related to

Sort By:
Pageof 9
Journal of Virology|November 15, 2022
Transient T Cell Expansion, Activation, and Proliferation in Therapeutically Vaccinated Simian Immunodeficiency Virus-Positive Macaques Treated with N-803Olivia E Harwood, Alexis J Balgeman, Abigail J Weaver, et al.
Frontiers in Virology (Lausanne, Switzerland)|June 29, 2023
Evaluation of the immunogenicity and efficacy of an rVSV vaccine against Zika virus infection in macaca nemestrinaJennifer Tisoncik-Go, Kathleen M Voss, Thomas B Lewis, et al.
Frontiers in Immunology|June 4, 2025
SIV/SARS-CoV-2 coinfection in rhesus macaques impacts viral shedding, host immunity, the microbiome, and viral evolutionMegan N Fredericks, Zohar Kolodner, Adam Waalkes, et al.
Research Square|April 8, 2025
SIV/SARS-CoV-2 co-infection in rhesus macaques impacts viral shedding, host immunity, the microbiome, and viral evolutionMegan N Fredericks, Zohar Kolodner, Adam Waalkes, et al.
Science Translational Medicine|July 19, 2019
Enhancing safety of cytomegalovirus-based vaccine vectors by engaging host intrinsic immunityEmily E Marshall, Daniel Malouli, Scott G Hansen, et al.
Plos Computational Biology|April 2, 2019
Prediction of VRC01 neutralization sensitivity by HIV-1 gp160 sequence featuresCraig A Magaret, David C Benkeser, Brian D Williamson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 9, 2023
T-SPOT.TB Reactivity in Southern African Children With and Without in Utero Human Immunodeficiency Virus ExposureSaori C Iwase, Paul T Edlefsen, Lynnette Bhebhe, et al.
Biorxiv : the Preprint Server for Biology|August 19, 2022
A replicon RNA vaccine induces durable protective immunity from SARS-CoV-2 in nonhuman primates after neutralizing antibodies have wanedMegan A Oâ Connor, David W Hawman, Kimberly Meade-White, et al.
Plos One|January 24, 2019
Cytomegalovirus vectors expressing Plasmodium knowlesi antigens induce immune responses that delay parasitemia upon sporozoite challengeScott G Hansen, Jennie Womack, Isabel Scholz, et al.
Ebiomedicine|January 20, 2015
Vaccine-induced Human Antibodies Specific for the Third Variable Region of HIV-1 gp120 Impose Immune Pressure on Infecting VirusesSusan Zolla-Pazner, Paul T Edlefsen, Morgane Rolland, et al.
Pageof 9